State of the Art Analytical Methods for the Characterization of Biological Products and Assessment of Comparability: Proceedings.3805579985 State of the art analytical methods for the characterization of biological products and assessment of comparability; proceedings. State of the Art Analytical Methods for the Characterization of Biological Products... (2003: Bethesda, MD) Ed. by Anthony R. Mire-Sluis. S. Karger, AG 2005 213 pages $182.00 Paperback Developments in biologicals; v.122 RS189 The papers of this proceedings were delivered at an eponymous e·pon·y·mous adj. Of, relating to, or constituting an eponym. [From Greek ep  numos; see eponym. conference held at the National Institutes of Health in Bethesda,
Maryland Bethesda is an urbanized, but unincorporated, area in southern Montgomery County, Maryland, just Northwest of Washington, D.C. It takes its name from a church located there, the Bethesda Presbyterian Church, built in 1820 and rebuilt in 1850, which in turn took its name from in June 2003 and organized by the Center for Biologics
Evaluation and Research The Center for Biologics Evaluation and Research (CBER) is one of six main centers for the Food and Drug Administration, which is in the United States Department of Health and Human Services. , the Center for Drugs Evaluation and Research,
the International Association for Biologicals, and the National
Institute for Biological Standards and Control. The papers are published
under the names of the seven conference sessions; three are on the
evaluation of standard and state of the art analytical technology; they
are on in primary sequence and post translational modifications,
structure, and functional assays. The remaining sessions are on aspects
of recombinant recombinant /re·com·bi·nant/ (re-kom´bi-nant)1. the new entity (e.g., gene, protein, cell, individual) that results from genetic recombination. 2. pertaining or relating to such an entity. See also under DNA. products, so-called "natural" products, in vivo in vivo /in vi·vo/ (ve´vo) [L.] within the living body. in vi·vo adj. Within a living organism. in vivo adv. activity, and the cause and impact of immunogenicity immunogenicity /im·mu·no·ge·nic·i·ty/ (-je-nis´it-e) the property enabling a substance to provoke an immune response, or the degree to which a substance possesses this property. of biological products. The contributors are researchers with private companies or the national institutions that sponsored the conference. Some are in the UK. The volume is not indexed. ([c]20062005 Book News, Inc., Portland, OR) |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion